
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, and quality of life.
The American Journal of Managed Care
almost 27 years ago
The Impact of Health Insurance Market Reforms on Market Competitionalmost 27 years ago
Acne Vulgaris: Pathogenesis and Therapeutic Approachalmost 27 years ago
Parkinson's Disease: Focus on Management Alternativesalmost 27 years ago
The Future of Health Status Assessmentalmost 27 years ago
Regulating the Pharmaceutical Industry: Who Really Benefits?almost 27 years ago
Can Peer-Comparison Feedback Improve Patient Functional Status?





